TriVascular Technologies, Inc.
Healthcare · Surgical & Medical Instruments & Apparatus · DE · SEC filings ↗ · Compare ⊕
Financials
SEC XBRL · annual| FY14 | FY13 | FY12 | |
|---|---|---|---|
| Revenue | $7.0M | $2.9M | $5.4M |
| Operating income | −$12.6M | −$9.7M | −$34.4M |
| Net income | −$14.4M | −$11.3M | −$43.3M |
| Total assets | $108.5M | $64.7M | — |
| Total liabilities | $69.0M | $53.5M | — |
| Equity | $39.6M | −$228.8M | −$179.8M |
| EPS (diluted) | — | — | — |
| Shares out. | 20.2M | 580,458 | — |
Reported figures from the company's SEC filings (XBRL). Blank where a line item isn't cleanly tagged — never estimated.
Key ratios
from filings · FY2014- Operating margin
- −179.5%
- Net margin
- −205.0%
- Return on equity
- −36.4%
- Return on assets
- −13.3%
- Return on capital (ROCE)
- −12.9%
- Liabilities / assets
- 63.5%
- Debt / equity
- 1.74×
- Book value / share
- $1.96
- Revenue growth (YoY)
- 139.1%
- Net income growth (YoY)
- —
Computed from the company's own SEC figures — no market price, so these are facts, not a valuation. Book value per share is reported equity ÷ shares; it is not the stock price.
Financial health
forensic scores · FY2014- Altman Z″ (distress)
- -3.83distress
- Accruals / assets
- 36.1%high accruals
- Piotroski F-Score
- 5/9mixed
Altman Z″is a textbook bankruptcy-distress score from book values only (>2.6 safe · 1.1–2.6 grey · <1.1 distress). Accruals = (net income − operating cash flow) ÷ assets; persistently high accruals are an earnings-quality red flag. Beneish M-Scoreis an eight-ratio screen comparing this year with last (M > −1.78 = elevated manipulation-risk screen, not proof). Piotroski F-Scorecounts how many of nine fundamental-health checks pass (shown as passed / applicable; we use operating margin and total liabilities as documented proxies where the exact input isn't XBRL-tagged). Computed from SEC filings — descriptive factors, not advice or a forecast.
Quality score
EDS ScoreOur own multi-factor score from free SEC data — profitability, growth, financial strength, earnings quality, and event/ownership catalysts. No market price and no licensed model: each axis is the share of source-backed checks it passes. Descriptive factors, not advice or a forecast.
Signs
● 1 severe● 4 warning● 1 good- Altman Z″ in the distress zone
- Operating losses (negative operating margin)
- Reported a net loss
- Negative operating cash flow
- High accruals — earnings-quality risk
- Revenue is growing year-over-year
Derived from the company's own SEC figures (fundamentals, forensic scores, filing discipline) — descriptive factors, not advice or a forecast.
Material events
SEC Form 8-K · most recent- Terminated a material agreement · Completed an acquisition or disposition · Delisting / listing-standard notice · Modified shareholder rights · Change in control · Director / officer change · Amended charter or bylaws · Other material eventFeb 3, 2016
- Results of operationsNov 9, 2015
- Entered a material agreement · Other material eventOct 26, 2015
- Results of operationsOct 26, 2015
- Results of operationsAug 4, 2015
- Entered a material agreement · New financial obligation · Unregistered equity saleAug 4, 2015
- Entered a material agreementMay 29, 2015
- Shareholder voteMay 27, 2015
Events the company reported on Form 8-K, labelled by the SEC item code it filed under — its own classification, not our interpretation.
Recent SEC filings
All filings ↗- SC 13D/AApr 8, 2016
- SC 13G/AMar 10, 2016
- 15-12BFeb 17, 2016
- SC 13G/AFeb 16, 2016
- SC 13G/AFeb 16, 2016
- SC 13G/AFeb 12, 2016
- SC 13G/ASEC SCHEDULE 13GFeb 11, 2016
- SC 13DFeb 10, 2016
- S-8 POSFeb 5, 2016
- S-8 POSFeb 5, 2016
- RWFeb 5, 2016
- RWFeb 5, 2016
- 4FORM 4 SUBMISSIONFeb 5, 2016
- 4FORM 4 SUBMISSIONFeb 5, 2016
- 4PRIMARY DOCUMENTFeb 4, 2016